|
|||||
|
|
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized,placebo-controlled trial |
|
| Authors: | Lesley M Arnold Fujun Wang Jonna Ahl Paula J Gaynor Madelaine M Wohlreich |
| Affiliation: | (1) Women’s Health Research Program, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 222 Piedmont Avenue, Suite 8200, Cincinnati, OH 45219, USA;(2) Statistics, MedImmune, LLC, 35 W. Watkins Mill Road, Gaithersburg, MD 20878, USA;(3) Scientific Communications, Lilly USA, LLC, Drop Code 4125 Indianapolis, IN 46285, USA;(4) Clinical Research, Lilly USA, LLC, Drop Code 4125 Indianapolis, IN 46285, USA |
| Abstract: | IntroductionFatigue is one of the most disabling symptoms associated with fibromyalgia that greatly impacts quality of life. Fatigue was assessed as a secondary objective in a 2-phase, 24-week study in outpatients with American College of Rheumatology-defined fibromyalgia. |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |